These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Granulomatosis with polyangiitis and microscopic polyangiitis]. Klapa S; Arnold S; Lamprecht P Laryngorhinootologie; 2024 Jul; 103(7):490-499. PubMed ID: 38211619 [TBL] [Abstract][Full Text] [Related]
27. The performance of the chemiluminescent immunoassay for measuring serum myeloperoxidase and proteinase 3 antibodies. Hou X; Liu J; Wang T; Zhou J; Cui L J Clin Lab Anal; 2021 Feb; 35(2):e23615. PubMed ID: 33034910 [TBL] [Abstract][Full Text] [Related]
28. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients. Cornec D; Cornec-Le Gall E; Fervenza FC; Specks U Nat Rev Rheumatol; 2016 Oct; 12(10):570-9. PubMed ID: 27464484 [TBL] [Abstract][Full Text] [Related]
29. Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives. Pecher AC; Henes M; Henes JC Arch Gynecol Obstet; 2023 Aug; 308(2):379-385. PubMed ID: 36104505 [TBL] [Abstract][Full Text] [Related]
30. Characteristics of granulomatosis with polyangiitis patients in Japan. Tsuchida Y; Shibuya M; Shoda H; Sumitomo S; Kubo K; Setoguchi K; Fujio K; Yamamoto K Mod Rheumatol; 2015 Mar; 25(2):219-23. PubMed ID: 25065919 [TBL] [Abstract][Full Text] [Related]
31. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study. Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610 [TBL] [Abstract][Full Text] [Related]
32. ANCA detection with solid phase chemiluminescence assay: diagnostic and severity association in vasculitis. Renuncio-García M; Calvo-Río V; Benavides-Villanueva F; Al Fazazi S; Rodríguez-Vidriales M; Escagedo-Cagigas C; Martín-Penagos L; Irure-Ventura J; López-Hoyos M; Blanco R Immunol Res; 2024 Feb; 72(1):128-133. PubMed ID: 37676628 [TBL] [Abstract][Full Text] [Related]
33. Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patterns. Oristrell J; Loureiro-Amigo J; Solans R; Valenzuela MP; Monsálvez V; Segarra A; Amengual MJ; Marín A; Feijoo C; Tolosa C Clin Exp Immunol; 2021 Feb; 203(2):209-218. PubMed ID: 33020895 [TBL] [Abstract][Full Text] [Related]
34. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Csernok E; Ahlquist D; Ullrich S; Gross WL Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006 [TBL] [Abstract][Full Text] [Related]
35. Value of non-identified ANCA (non-PR3, non-MPO) in the diagnosis of granulomatosis with polyangiitis (Wegener's granulomatosis). Givaudan M; Vandergheynst F; Stordeur P; Ocmant A; Melot C; Gangji V; Soyfoo MS Acta Clin Belg; 2017 Oct; 72(5):313-317. PubMed ID: 28067125 [TBL] [Abstract][Full Text] [Related]
36. Application of the 2022 ACR/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis. Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW Clin Exp Rheumatol; 2023 Apr; 41(4):792-799. PubMed ID: 35616581 [TBL] [Abstract][Full Text] [Related]
37. Spectrum of ANCA-specificities in eosinophilic granulomatosis with polyangiitis. A retrospective multicentre study. Arnold S; Mahrhold J; Kerstein-Staehle A; Riemekasten G; Csernok E; Hellmich B; Venhoff N; Thiel J; Affeldt K; Jahnke A; Lamprecht P Clin Exp Rheumatol; 2023 Apr; 41(4):936-942. PubMed ID: 37073637 [TBL] [Abstract][Full Text] [Related]
38. Bronchiectasis is highly prevalent in anti-MPO ANCA-associated vasculitis and is associated with a distinct disease presentation. Néel A; Espitia-Thibault A; Arrigoni PP; Volteau C; Rimbert M; Masseau A; Agard C; Fakhouri F; Liberge R; Hamidou M Semin Arthritis Rheum; 2018 Aug; 48(1):70-76. PubMed ID: 29336783 [TBL] [Abstract][Full Text] [Related]
39. [The clinical analysis of 46 cases with antineutrophil cytoplasmic antibody-associated vasculitis]. Zhang Q; Zhou HQ; Li YH; Guo J; Xu PH; Lu MH; Liu XL; Wang L; Li SG Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2146-9. PubMed ID: 27464538 [TBL] [Abstract][Full Text] [Related]
40. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis. Holding S; Fisher VJ; Abuzakouk M Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]